Enzo Life Sciences Exendin-4 GLP-1 receptor agonist

Thursday, 12 June, 2014 | Supplied by: United Bioresearch Products Pty Ltd

Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.

Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Abcalis Multiclonal Recombinant Secondary Antibodies

Multiclonals consist of defined mixtures of carefully selected individual recombinant monoclonal...

GeneTex ion channel antibodies

GeneTex offers a wide selection of antibodies to support ion channel research, with IHC-validated...

AMSL Scientific CompactDry Total Count Rapid (TCR)

Next-day results are available with CompactDry TCR for total viable counts — an...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd